US Bancorp’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-1,909
| Closed | -$37K | – | 3789 |
|
|
2018
Q1 | $37K | Buy |
1,909
+29
| +2% | +$569 | ﹤0.01% | 2746 |
|
|
2017
Q4 | $31K | Buy |
1,880
+864
| +85% | +$15.8K | ﹤0.01% | 2791 |
|
|
2017
Q3 | $21K | Hold |
1,016
| – | – | ﹤0.01% | 2893 |
|
|
2017
Q2 | $16K | Buy |
1,016
+654
| +181% | +$9.66K | ﹤0.01% | 2958 |
|
|
2017
Q1 | $5K | Buy |
362
+120
| +50% | +$1.45K | ﹤0.01% | 3230 |
|
|
2016
Q4 | $3K | Buy |
+242
| New | +$4.14K | ﹤0.01% | 3352 |
|
|
2016
Q3 | – | Sell |
-149
| Closed | -$4K | – | 3695 |
|
|
2016
Q2 | $4K | Sell |
149
-11
| -7% | -$359 | ﹤0.01% | 3258 |
|
|
2016
Q1 | $5K | Hold |
160
| – | – | ﹤0.01% | 3195 |
|
|
2015
Q4 | $7K | Sell |
160
-13
| -8% | -$519 | ﹤0.01% | 3162 |
|
|
2015
Q3 | $6K | Sell |
173
-27
| -14% | -$1.22K | ﹤0.01% | 3227 |
|
|
2015
Q2 | $9K | Sell |
200
-729
| -78% | -$34.6K | ﹤0.01% | 3175 |
|
|
2015
Q1 | $43K | Sell |
929
-574
| -38% | -$22.8K | ﹤0.01% | 2619 |
|
|
2014
Q4 | $48K | Sell |
1,503
-135
| -8% | -$3.95K | ﹤0.01% | 2557 |
|
|
2014
Q3 | $39K | Sell |
1,638
-1,785
| -52% | -$45.7K | ﹤0.01% | 2610 |
|
|
2014
Q2 | $103K | Sell |
3,423
-2,296
| -40% | -$61.9K | ﹤0.01% | 2118 |
|
|
2014
Q1 | $151K | Buy |
5,719
+565
| +11% | +$14.1K | ﹤0.01% | 1914 |
|
|
2013
Q4 | $130K | Buy |
5,154
+1,154
| +29% | +$25.7K | ﹤0.01% | 1963 |
|
|
2013
Q3 | $82K | Sell |
4,000
-300
| -7% | -$6.2K | ﹤0.01% | 2125 |
|
|
2013
Q2 | $86K | Buy |
+4,300
| New | +$76.3K | ﹤0.01% | 2064 |
|
US Bancorp's IPXL Position: Q2 2018 in Review
US Bancorp sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 1,909 shares — an estimated $37K sold.
US Bancorp first reported a position in IPXL in Q2 2013 and held it in 19 quarters. The position peaked at $151K in Q1 2014. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- US Bancorp reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- US Bancorp sold 1,909 Impax Laboratories, Inc. shares in Q2 2018, an estimated $37K.
- US Bancorp first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 19 quarters.
- US Bancorp's Impax Laboratories, Inc. position peaked at $151K in Q1 2014.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on US Bancorp's 13F filing for Q2 2018, filed 8 Aug 2018.